NO996468L - Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer - Google Patents

Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer

Info

Publication number
NO996468L
NO996468L NO996468A NO996468A NO996468L NO 996468 L NO996468 L NO 996468L NO 996468 A NO996468 A NO 996468A NO 996468 A NO996468 A NO 996468A NO 996468 L NO996468 L NO 996468L
Authority
NO
Norway
Prior art keywords
gabapentin
inflammatory diseases
medicament
manufacture
treatment
Prior art date
Application number
NO996468A
Other languages
English (en)
Other versions
NO996468D0 (no
NO329321B1 (no
Inventor
Denis Schrier
Jr Charles Price Taylor
Karin Nanette West-Lund-High
Original Assignee
Warner Lambert Co
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996468(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co, Univ Texas filed Critical Warner Lambert Co
Publication of NO996468D0 publication Critical patent/NO996468D0/no
Publication of NO996468L publication Critical patent/NO996468L/no
Publication of NO329321B1 publication Critical patent/NO329321B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19996468A 1997-06-25 1999-12-23 Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer NO329321B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5073697P 1997-06-25 1997-06-25
US8418398P 1998-05-04 1998-05-04
PCT/US1998/013107 WO1998058641A1 (en) 1997-06-25 1998-06-24 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases

Publications (3)

Publication Number Publication Date
NO996468D0 NO996468D0 (no) 1999-12-23
NO996468L true NO996468L (no) 2000-02-21
NO329321B1 NO329321B1 (no) 2010-09-27

Family

ID=26728613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996468A NO329321B1 (no) 1997-06-25 1999-12-23 Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer

Country Status (20)

Country Link
EP (1) EP0994704B1 (no)
JP (2) JP3884486B2 (no)
KR (1) KR100554319B1 (no)
AT (1) ATE297722T1 (no)
AU (1) AU735675B2 (no)
CA (1) CA2294607C (no)
CO (1) CO4940456A1 (no)
DE (1) DE69830586T2 (no)
DK (1) DK0994704T3 (no)
ES (1) ES2244070T3 (no)
HR (1) HRP980342A2 (no)
HU (1) HU228454B1 (no)
IL (2) IL132709A0 (no)
IS (1) IS2279B (no)
NO (1) NO329321B1 (no)
NZ (1) NZ501626A (no)
PL (1) PL191370B1 (no)
PT (1) PT994704E (no)
SI (1) SI0994704T1 (no)
WO (1) WO1998058641A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
DE69834204T2 (de) 1997-10-27 2007-03-29 Warner-Lambert Co. Llc Zyklische aminosäuren und deren derivate als arzneimittel
AU2463099A (en) * 1998-01-23 1999-08-09 Warner-Lambert Company Gabapentin and its derivatives for the treatment of muscular and skeletal pain
EP0974351A3 (en) * 1998-04-24 2000-12-13 Jouveinal Medicament for preventing and treating gastrointestinal damage
DE60034344T2 (de) 1999-07-22 2008-01-10 University Of Rochester Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen
US6620829B2 (en) * 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
EP2240158A2 (en) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
IN2012MN02923A (no) 2010-06-01 2015-06-05 Rubicon Res Private Ltd
TW201613625A (en) * 2014-08-29 2016-04-16 Wakamoto Pharma Co Ltd Lactic acid bacteria-containing composition
GB201617380D0 (en) 2016-10-13 2016-11-30 St George's Hospital Medical School Treatment for Osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS6036413A (ja) * 1983-08-09 1985-02-25 Kaneshiro Nagai 炎症治癒促進剤
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JPH0636413A (ja) * 1992-07-21 1994-02-10 Nakamichi Corp テ−プレコ−ダのテ−プガイド装置
CN1094757C (zh) * 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
WO1998017627A1 (en) * 1996-10-23 1998-04-30 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents

Also Published As

Publication number Publication date
ES2244070T3 (es) 2005-12-01
JP2006298929A (ja) 2006-11-02
JP2002506449A (ja) 2002-02-26
DE69830586T2 (de) 2005-12-15
DK0994704T3 (da) 2005-10-03
PT994704E (pt) 2005-08-31
NO996468D0 (no) 1999-12-23
HRP980342A2 (en) 1999-02-28
CA2294607C (en) 2007-09-25
IS2279B (is) 2007-09-15
IS5239A (is) 1999-11-05
NZ501626A (en) 2002-03-28
WO1998058641A1 (en) 1998-12-30
ATE297722T1 (de) 2005-07-15
NO329321B1 (no) 2010-09-27
HUP0003730A3 (en) 2002-01-28
KR100554319B1 (ko) 2006-02-22
EP0994704B1 (en) 2005-06-15
IL132709A (en) 2006-10-05
CO4940456A1 (es) 2000-07-24
CA2294607A1 (en) 1998-12-30
HUP0003730A1 (hu) 2001-04-28
HU228454B1 (en) 2013-03-28
AU735675B2 (en) 2001-07-12
AU8375898A (en) 1999-01-04
SI0994704T1 (en) 2005-10-31
JP3884486B2 (ja) 2007-02-21
KR20010020509A (ko) 2001-03-15
JP4452255B2 (ja) 2010-04-21
PL191370B1 (pl) 2006-05-31
EP0994704A1 (en) 2000-04-26
IL132709A0 (en) 2001-03-19
PL337847A1 (en) 2000-09-11
DE69830586D1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
NO996468L (no) Anvendelse av gaba-analoger slik som gabapentin i fremstillingen av et medikament for behandling av betennelsessykdommer
ATE388699T1 (de) Phenylacetate und derivate, allein oder in kombination mit anderen verbindungen, zur behandlung von neoplastischen und anderen erkrankungen
NO2008018I2 (no) (3S)-3-(Aminometyl)-5-metylheksansyre (Pregabalin)eller et farmasøytisk akseptabelt salt derav
PT1239849E (pt) Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
DK0696456T3 (da) Kombination af nekrosefremkaldende stoffer med stoffer, som aktiveres af nekroser, til selektiv behandling af tumorer og betændelsessygdomme
NO20040907L (no) Farmasoytisk sammensetning som innbefatter gabapentin eller en analog derav og et alfa-aminoamid og dens anvendelse som smertestillende middel
DK0977560T3 (da) Ibuprofen-thioestere som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer (CoA-thioestere af arylpropionsyrer, aryleddikesyrer og salicylater som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer)
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
DE3480764D1 (de) Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
BR9812265A (pt) Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.
ATE305778T1 (de) Behandlung von nierenkolik mit gaba-analogen

Legal Events

Date Code Title Description
MK1K Patent expired